Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
SEW2871
Cat. No.:
OB0225LY-0085
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and LC-MS.
Size:
Product Overview
Description:
SEW 2871 is an S1P1 receptor agonist that has been used primarily to study its role in immunomodulation and cardiovascular disease.
Synonym:
SEW2871; 256414-75-2; 5-[4-Phenyl-5-(trifluoromethyl)-2-thienyl]-3-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole; SEW-2871; 5-(4-Phenyl-5-(trifluoromethyl)thiophen-2-yl)-3-(3-(trifluoromethyl)phenyl)-1,2,4-oxadiazole
CAS No.:
256414-75-2
Compound CID:
4077460
Formula:
C20H10F6N2OS
Formula Weight:
440.36
Specification
Relative Density:
1.415 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
SEW 2871 has potential application in anti-chronic immune disease and cardiovascular disease models.
Library Information
Targets:
S1P receptor; LPL receptor
Receptors:
LPL; S1P1
Pathways:
GPCR/G protein
Plate Number:
AOCL-2
Plate Location:
a8
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
8.8 mg/mL; 20 mM
